Leerink Partners analyst Andrew Berens reiterated an Outperform rating and $19.00 price target on Tango Therapeutics Inc. (NASDAQ: TNGX).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE